ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Re: First-time drug candidate disclosures at #ACSSanDiego

March 28, 2016 | APPEARED IN VOLUME 94, ISSUE 13

Photography of presentations was prohibited at the Division of Medicinal Chemistry’s “First-Time Disclosures” symposium held earlier this month at the ACS national meeting in San Diego, but that didn’t stop Senior Editor Bethany Halford from live-tweeting her own hand-drawn structures of the pharmaceuticals being unveiled.

Seeing Halford’s re-creation of Pfizer’s anticancer drug candidate PF-06650808 (shown), Jake Yeston (@JakeYeston) marveled, “I hope @cenmag is paying @beth_halford by the atom for this. I’m in awe!” And Halford’s efforts were enough to make Dave Gibboni opine on Facebook: “The great art of chemical structure drawing. It is one of the things that distinguishes us chemists from others: We can communicate with each other in our own system of ‘writing.’ ”

http://cenm.ag/disclose2016

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment